ZIOPHARM Oncology, Inc.Home | Contact Us | Sitemap
About UsClinical DevelopmentPartnershipsPatientsInvestorsPress and Media




Investors




| Investors Home | Stock Performance | Financial Reports | Events & Presentations | Corporate Governance | Shareholder Services | Investor Toolkit | Contact Us |

INSIDER OWNERSHIP

Related Links

Print Print page | Email Email page

Name Relationship / Title Current Shares Trading Activity
bagley richard e Officer 25,000 View
brennan murray Director 0 View
cannon james anthony Director 0 View
essex woodlands health ventures fund vi l p Beneficial Owner (10% or more) 1,913,876 View
fowler wyche Director 0 View
fragin gary s Director 0 View
gale robert peter Officer 0 View
lewis jonathan Officer 105,000 View
mcinerney timothy Director 63,205 View
paloma international l p Beneficial Owner (10% or more) 1,214,456 View
rosenwald lindsay a md Beneficial Owner (10% or more) 737,777 View
schwartz brian Officer 25,000 View
weiser michael Director 0 View

Stock transaction information provided by EDGAR Online. ZIOPHARM Oncology, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Stock Information
ZIOP - (NASD)
$1.82   + 0.02
Jul 3, 2008
1:00 PM ET